Citadel Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-195,601
| Closed | -$16.6M | – | 10611 |
|
|
2019
Q4 | $16.6M | Sell |
195,601
-26,483
| -12% | -$1.77M | 0.01% | 1660 |
|
|
2019
Q3 | $11.1M | Sell |
222,084
-330,586
| -60% | -$13.2M | 0.01% | 2091 |
|
|
2019
Q2 | $20.2M | Buy |
552,670
+166,559
| +43% | +$5.44M | 0.01% | 1421 |
|
|
2019
Q1 | $10.8M | Sell |
386,111
-198,774
| -34% | -$4.68M | 0.01% | 1970 |
|
|
2018
Q4 | $11.2M | Buy |
584,885
+430,929
| +280% | +$10M | 0.01% | 1773 |
|
|
2018
Q3 | $4.61M | Buy |
153,956
+129,633
| +533% | +$4.88M | ﹤0.01% | 3117 |
|
|
2018
Q2 | $893K | Buy |
24,323
+2,616
| +12% | +$85K | ﹤0.01% | 5419 |
|
|
2018
Q1 | $715K | Sell |
21,707
-338,024
| -94% | -$10.6M | ﹤0.01% | 5297 |
|
|
2017
Q4 | $9.84M | Buy |
359,731
+299,268
| +495% | +$9.22M | 0.01% | 1749 |
|
|
2017
Q3 | $2.24M | Sell |
60,463
-108,124
| -64% | -$3.99M | ﹤0.01% | 3273 |
|
|
2017
Q2 | $6.41M | Buy |
+168,587
| New | +$7.51M | 0.01% | 1855 |
|
|
2016
Q4 | – | Sell |
-326,646
| Closed | -$11.6M | – | 8145 |
|
|
2016
Q3 | $12.3M | Buy |
326,646
+121,747
| +59% | +$4.59M | 0.01% | 1191 |
|
|
2016
Q2 | $6.89M | Sell |
204,899
-272,867
| -57% | -$9.62M | 0.01% | 1548 |
|
|
2016
Q1 | $15.2M | Buy |
477,766
+463,049
| +3,146% | +$15.1M | 0.02% | 912 |
|
|
2015
Q4 | $550K | Sell |
14,717
-701,041
| -98% | -$26.5M | ﹤0.01% | 4347 |
|
|
2015
Q3 | $27.2M | Buy |
715,758
+692,998
| +3,045% | +$24.3M | 0.03% | 716 |
|
|
2015
Q2 | $651K | Sell |
22,760
-206,962
| -90% | -$5.77M | ﹤0.01% | 4569 |
|
|
2015
Q1 | $6.44M | Sell |
229,722
-589,910
| -72% | -$16.6M | 0.01% | 1784 |
|
|
2014
Q4 | $22.7M | Buy |
819,632
+770,839
| +1,580% | +$19.1M | 0.02% | 849 |
|
|
2014
Q3 | $1.09M | Buy |
48,793
+43,982
| +914% | +$1.12M | ﹤0.01% | 3608 |
|
|
2014
Q2 | $140K | Buy |
+4,811
| New | +$128K | ﹤0.01% | 5924 |
|
|
2014
Q1 | – | Sell |
-4,219
| Closed | -$140K | – | 8113 |
|
|
2013
Q4 | $163K | Sell |
4,219
-356,485
| -99% | -$12.7M | ﹤0.01% | 5223 |
|
|
2013
Q3 | $12.1M | Buy |
360,704
+291,118
| +418% | +$9.27M | 0.02% | 992 |
|
|
2013
Q2 | $2.14M | Buy |
+69,586
| New | +$2.33M | ﹤0.01% | 2425 |
|
Other funds holding MDCO
Citadel Advisors's MDCO Position: Q1 2020 in Review
Citadel Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 195,601 shares — an estimated $16.6M sold.
Citadel Advisors first reported a position in MDCO in Q2 2013 and held it in 24 quarters. The position peaked at $27.2M in Q3 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Citadel Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Citadel Advisors sold 195,601 Medicines Co shares in Q1 2020, an estimated $16.6M.
- Citadel Advisors first reported a position in Medicines Co in Q2 2013 and held it in 24 quarters.
- Citadel Advisors's Medicines Co position peaked at $27.2M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.